Primary Care Clinics in Byram, MS Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Mea Medical Clinics Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7300 S Siwell Rd, Byram, MS 39272 Phone: 601-373-1234 Fax: 601-373-1397 |
Byram Family Physicians Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7215 S Siwell Rd, Byram, MS 39272 Phone: 601-373-2204 Fax: 601-373-4413 |
Gary Road Elementary School Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 7241 Gary Rd, Byram, MS 39272 Phone: 601-892-4053 |
Gary Road Intermediate School Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 7255 Gary Rd, Byram, MS 39272 Phone: 601-894-8590 |
Mea Primary Care Plus, Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7300 S Siwell Rd, Byram, MS 39272 Phone: 601-373-1234 Fax: 601-373-1397 |
Nps On Call, Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Southpointe Dr, Byram, MS 39272 Phone: 601-724-9252 |
Quad Intermed Company Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 7300 S Siwell Rd, Byram, MS 39272 Phone: 601-373-1234 |
News Archive
Florida stands 41st on maternal mortality ranking with 13.1 deaths per 100,000 live births
In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that Florida is 41st on a maternal mortality ranking, with 13.1 deaths per 100,000 live births.
Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke
A major Canadian-led global study has found that an inexpensive anti-blood-clotting drug significantly reduces death and repeat heart attacks without increasing the risk of stroke.
AOAC Research Institute certifies Idaho's E.coli O157:H7 test
Idaho Technology, Inc. (ITI) has been granted Performance Tested Methods Status by the AOAC Research Institute (Certificate No. 100901) for its E.coli O157:H7 test used with the R.A.P.I.D.® LT Food Security System (FSS). The assay uses real-time PCR technology to identify the presence of E.coli O157:H7 in raw ground beef and uncooked spinach food samples.
Malaria drug may help those with hereditary hearing loss finds study
Researchers have found that anti-malarial drug artemisinin could help patients with genetic or hereditary hearing loss. The study results were published in the latest issue of the journal Proceedings of the National Academy of Sciences (PNAS). The study was titled, "Unconventional secretory pathway activation restores hair cell mechanotransduction in an USH3A model."
Nuvo Research reports net income in fourth-quarter, driven by FDA approval of Pennsaid
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the year and the fourth quarter ended December 31, 2009.
› Verified 3 days ago